Search Results - "Houben, Roland"

Refine Results
  1. 1

    Reduced frequency of migraine attacks following coronavirus disease 2019: a case report by Houben, Roland

    Published in Journal of medical case reports (22-02-2023)
    “…Severe acute respiratory syndrome coronavirus 2 is a virus affecting different organs and causing a wide variety and severity of symptoms. Headache as well as…”
    Get full text
    Journal Article
  2. 2

    IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression by Thiem, Alexander, Hesbacher, Sonja, Kneitz, Hermann, di Primio, Teresa, Heppt, Markus V, Hermanns, Heike M, Goebeler, Matthias, Meierjohann, Svenja, Houben, Roland, Schrama, David

    “…Immune checkpoint inhibition and in particular anti-PD-1 immunotherapy have revolutionized the treatment of advanced melanoma. In this regard, higher tumoral…”
    Get full text
    Journal Article
  3. 3

    Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens by Houben, Roland, Shuda, Masahiro, Weinkam, Rita, Schrama, David, Feng, Huichen, Chang, Yuan, Moore, Patrick S, Becker, Jürgen C

    Published in Journal of Virology (01-07-2010)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Membrane-binding and activation of LKB1 by phosphatidic acid is essential for development and tumour suppression by Dogliotti, Giada, Kullmann, Lars, Dhumale, Pratibha, Thiele, Christian, Panichkina, Olga, Mendl, Gudrun, Houben, Roland, Haferkamp, Sebastian, Püschel, Andreas W., Krahn, Michael P.

    Published in Nature communications (26-06-2017)
    “…The serine/threonine kinase LKB1 regulates various cellular processes such as cell proliferation, energy homeostasis and cell polarity and is frequently…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Merkel Cell Polyomavirus Large T Antigen is Dispensable in G2 and M-Phase to Promote Proliferation of Merkel Cell Carcinoma Cells by Houben, Roland, Ebert, Marlies, Hesbacher, Sonja, Kervarrec, Thibault, Schrama, David

    Published in Viruses (14-10-2020)
    “…Merkel cell carcinoma (MCC) is an aggressive skin cancer frequently caused by the Merkel cell polyomavirus (MCPyV), and proliferation of MCPyV-positive MCC…”
    Get full text
    Journal Article
  10. 10

    Activation of the PI3K/AKT pathway in Merkel cell carcinoma by Hafner, Christian, Houben, Roland, Baeurle, Anne, Ritter, Cathrin, Schrama, David, Landthaler, Michael, Becker, Juergen C

    Published in PloS one (17-02-2012)
    “…Merkel cell carcinoma (MCC) is a highly aggressive skin cancer with an increasing incidence. The understanding of the molecular carcinogenesis of MCC is…”
    Get full text
    Journal Article
  11. 11

    Elucidating the mechanism of action of domatinostat (4SC-202) in cutaneous T cell lymphoma cells by Wobser, Marion, Weber, Alexandra, Glunz, Amelie, Tauch, Saskia, Seitz, Kristina, Butelmann, Tobias, Hesbacher, Sonja, Goebeler, Matthias, Bartz, René, Kohlhof, Hella, Schrama, David, Houben, Roland

    Published in Journal of hematology and oncology (18-03-2019)
    “…Targeting epigenetic modifiers is effective in cutaneous T cell lymphoma (CTCL). However, there is a need for further improvement of this therapeutic approach…”
    Get full text
    Journal Article
  12. 12

    Antibody-Drug Conjugates as an Emerging Therapy in Oncodermatology by Esnault, Clara, Schrama, David, Houben, Roland, Guyétant, Serge, Desgranges, Audrey, Martin, Camille, Berthon, Patricia, Viaud-Massuard, Marie-Claude, Touzé, Antoine, Kervarrec, Thibault, Samimi, Mahtab

    Published in Cancers (02-02-2022)
    “…Antibody-drug conjugates (ADCs) are an emerging class of therapeutics, with twelve FDA- and EMA-approved drugs for hematological and solid cancers. Such drugs…”
    Get full text
    Journal Article
  13. 13

    The HSP70 modulator MAL3-101 inhibits Merkel cell carcinoma by Adam, Christian, Baeurle, Anne, Brodsky, Jeffrey L, Wipf, Peter, Schrama, David, Becker, Jürgen Christian, Houben, Roland

    Published in PloS one (01-04-2014)
    “…Merkel Cell Carcinoma (MCC) is a rare and highly aggressive neuroendocrine skin cancer for which no effective treatment is available. MCC represents a human…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Expression of Merkelcell polyomavirus (MCPyV) large T-antigen in Merkel cell carcinoma lymph node metastases predicts poor outcome by Haymerle, Georg, Janik, Stefan, Fochtmann, Alexandra, Pammer, Johannes, Schachner, Helga, Nemec, Lucas, Mildner, Michael, Houben, Roland, Grasl, Matthaeus Ch, Erovic, Boban M

    Published in PloS one (01-08-2017)
    “…The aim of this study was to determine the prevalence of MCPyV in Merkel cell carcinoma (MCC) primaries versus lymph node metastasis and to evaluate possible…”
    Get full text
    Journal Article
  16. 16

    Overexpression of the KIT/SCF in Uveal Melanoma Does Not Translate into Clinical Efficacy of Imatinib Mesylate by Hofmann, Uta B., Kauczok-Vetter, Claudia S., Houben, Roland, Becker, Jürgen C.

    Published in Clinical cancer research (01-01-2009)
    “…Purpose: Recently, gene amplification and overexpression of KIT as well as activating mutations in the KIT gene have been described to occur in certain subsets…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Molecular pathogenesis of Merkel cell carcinoma by Houben, Roland, Schrama, David, Becker, Jürgen C.

    Published in Experimental dermatology (01-03-2009)
    “…:  Merkel cell carcinoma (MCC) is a highly aggressive neuroendocrine skin cancer which is twice as lethal as melanoma as more than one‐third of MCC patients…”
    Get full text
    Journal Article
  20. 20

    The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report by Becker, Jürgen C, Houben, Roland, Vetter, Claudia S, Bröcker, Eva B

    Published in BMC cancer (11-01-2006)
    “…Since tacrolimus ointment was approved by the U.S. Food and Drug Administration (FDA) as a promising treatment for atopic dermatitis, it has been approved in…”
    Get full text
    Journal Article